How this company measures up on the fundamentals that matter
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Trading at $58, 8% above fair value of $54. Passes all ethical screens. Ranks better than 87% of screened stocks.
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
Trading characteristics and market positioning
Balance sheet strength and cash generation — the foundation of long-term value
SEC Form 4 filings — what company insiders are buying and selling
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-12 | COUGHLIN CHRISTOPHER J | Director | 3,992 | — | |
| 2026-05-12 | SAMUELS THEODORE R II | Director | 3,992 | — | |
| 2026-05-12 | TANJI KENNETH Y. | Director | 3,992 | — | |
| 2026-05-12 | DALLAS HIRAM JAMES | Director | 3,992 | — | |
| 2026-05-12 | BURDICK KENNETH A | Director | 3,992 | — | |
| 2026-05-12 | BLUME JESSICA L | Director | 3,992 | — | |
| 2026-05-12 | EPPINGER FREDERICK H | Director | 6,654 | — | |
| 2026-05-12 | FORD MONTE E. | Director | 3,992 | — | |
| 2026-03-31 | COUGHLIN CHRISTOPHER J | Director | 1,140 | — | |
| 2026-03-31 | SAMUELS THEODORE R II | Director | 943 | — |
Congressional trading disclosures involving this instrument
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 14 Apr2026 | Thomas Kean Jr | Republican | sell | 1K–15K |
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15